2025. Efficacy and Safety of CD19-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy in Refractory Systemic Lupus Erythematosus: A Systematic Review of Clinical Outcomes and B-Cell Depletion Kinetics. Archives of The Medicine and Case Reports. 7, 1 (Dec. 2025), 1–18. DOI:https://doi.org/10.37275/amcr.v7i1.831.